Peer reviewed cancer research program (prcrp) meeting services

Ended Awarded Last action

Contract number
W81XWH20F0156
Awardee
Awarding agency
Obligated
$1,100,144

Award facts

Opportunity
Contract value 76% obligated
  • $1,100,143.54 Current, with exercised options
  • $1,454,028.68 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Two Step
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00009 · Peer reviewed cancer research program support services -$241,036
Funding Only Action P00008 · FY22 peer reviewed cancer research program (prcrp) -$112,849
Supplemental Agreement for work within scope P00007 · Per section 711 of the 2019 ndaa, usamraa transferred to DHA 10/1/2022. And add meeting assumptions. $0
Funding Only Action P00006 · Peer reviewed cancer research program $437,491
Other Administrative Action P00005 · FY22 peer reviewed cancer research program $48,992
Supplemental Agreement for work within scope P00004 · FY22 peer reviewed cancer research program (prcrp) $214,196
Funding Only Action P00003 · FY21 peer reviewed cancer research program (prcrp) $22,736
Exercise an Option P00002 · FY20 peer reviewed cancer research program $213,701
Funding Only Action P00001 · FY20 peer reviewed cancer research program (prcrp) meeting support $316,913
Original award $200,000

About this award

Leidos, Inc., operating through its Leidos Services Operating Segment Division, received a delivery order award valued at approximately $1.45 million from the Defense Health Agency (DHA) to provide meeting services and support services for the Peer Reviewed Cancer Research Program (PRCRP). The contract operates on a cost-plus-fixed-fee pricing model with an ultimate completion date of May 12, 2023, and was awarded on May 13, 2020. The work will be performed in Frederick, Maryland, the historical home of the National Cancer Institute and the hub of federal cancer research operations. This delivery order was issued without a small business set-aside designation, reflecting Leidos' competitive standing as a large established contractor capable of delivering specialized administrative and technical services for congressionally directed medical research initiatives.

The PRCRP, a congressionally appropriated program under DHA management, funds peer-reviewed cancer research proposals to advance understanding and treatment of various cancer types across the Department of Defense research portfolio. Leidos' support services in this context typically encompass program administration, meeting coordination, technical assistance, and operational support to facilitate the research funding process and program management activities. This award aligns with Leidos' broader portfolio of medical research support services, which includes comprehensive administrative and technical support across multiple defense health research initiatives, including cancer research, neurodegenerative disease research, and trauma and injury research programs managed by the Naval Health Research Center and DHA.

Quick answers

Who was awarded contract W81XWH20F0156?

W81XWH20F0156 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on May 13, 2020.

How much is contract W81XWH20F0156 worth?

The government has obligated $1,100,144 on W81XWH20F0156. Its potential value, with all options, is $1,454,029.

Is contract W81XWH20F0156 an order under another contract?

Yes. W81XWH20F0156 is a delivery order under W81XWH17D0025, an indefinite delivery contract.

Was contract W81XWH20F0156 competed?

The extent of competition for W81XWH20F0156 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award